Why the study?
Diabetes and diabetic autonomic neuropathy significantly increase sudden cardiac death risk, driven by oxidative stress and autonomic dysfunction.
Does (r) Alpha Lipoic Acid reduce sudden cardiac death in geriatric patients with type 2 diabetes mellitus and autonomic neuropathy?
Case Report (n=3)
Does (r) Alpha Lipoic Acid reduce sudden cardiac death in geriatric patients with type 2 diabetes mellitus and autonomic neuropathy?
(r)-Alpha Lipoic Acid was associated with a significant reduction in sudden cardiac death and favorable autonomic tone changes in geriatric patients with type 2 diabetes and autonomic neuropathy.
Answers are grounded in this paper and cite their sources.
Antioxidant treatment in diabetic CAN may reduce SCD risk; leaves open need for RCTs before any practice change.
Background: Diabetes carries a two-fold risk of Sudden Cardiac Death (SCD). Diabetic Autonomic Neuropathy (DAN), often progressing to Cardiovascular Autonomic Neuropathy (CAN, critically low parasympathetic tone [P]), increases death 3.5-fold over 5 years, half sudden or non- renal. Oxidative stress is a major cause of DAN. Also, increased sympathetic tone (S), High Sympathovagal Balance [SB>2.5] increases SCD risk. Objective: Dysautonomic diabetic II patients were treated with the antioxidant (r) Alpha Lipoic Acid (ALA), autonomic function followed, and Sudden Death (SD) compared to untreated patients. Methods: 133 patients (mean age 66y/o) with DAN or CAN, diagnosed using the ANX 3.0 Autonomic Monitor (Physio PS, Inc., Atlanta, GA) was offered (r)-ALA: 83 agreed (Group 1), and 50 refused (Group 2). P and S were re- measured up to 3 times/yr (mean f/u 6.31 yrs); SCDs were recorded. Results: A 43% Relative Risk Reduction (RRR) in SCD occurred with (r)- ALA (25% SCD Group 1 vs. 44% SCD Group 2, p=0.0076). Initial to final patients with high SB or CAN were 21.7%-12% (p=0.010), 10.8%- 15.7% (p=0.045), Group 1 vs. 24%-22% (p=ns), 6%-12% (p=0.083), Group 2. Only Group 1 survivors increased mean resting P. The progressive increase in P’s decline, increasing CAN risk, in the other patients correlated with mortality (p<0.001) and (r) ALA dose. Initially, Group 1 had insignificantly less high SB (p=0.449) and significantly more CAN (p=0.013) vs. Group 2. Finally, Group 1 had significantly less high SB (p=0.0967) vs. Group 2, also improving to insignificantly more CAN (p=0.261). Conclusion: (r)-ALA was associated with a 43% RRR of SCD and favorable P and S changes.
No takes yet. Share an insight, caveat, or question.
Murray et al. (2020) conducted a case report in Anxiety and mental illnesses (n=3). Chronic stress was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: